ATE401075T1 - Cytisinehaltiges arzneimittel - Google Patents
Cytisinehaltiges arzneimittelInfo
- Publication number
- ATE401075T1 ATE401075T1 AT05472001T AT05472001T ATE401075T1 AT E401075 T1 ATE401075 T1 AT E401075T1 AT 05472001 T AT05472001 T AT 05472001T AT 05472001 T AT05472001 T AT 05472001T AT E401075 T1 ATE401075 T1 AT E401075T1
- Authority
- AT
- Austria
- Prior art keywords
- cytisine
- product containing
- medicinal product
- tablets
- containing cytisine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BG108686A BG65536B1 (bg) | 2004-04-16 | 2004-04-16 | Лекарствена форма, съдържаща цитизин |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE401075T1 true ATE401075T1 (de) | 2008-08-15 |
Family
ID=34943361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05472001T ATE401075T1 (de) | 2004-04-16 | 2005-02-02 | Cytisinehaltiges arzneimittel |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1586320B1 (de) |
AT (1) | ATE401075T1 (de) |
BG (1) | BG65536B1 (de) |
DE (1) | DE602005008128D1 (de) |
PL (1) | PL1586320T3 (de) |
SI (1) | SI1586320T1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL220354B1 (pl) | 2012-11-19 | 2015-10-30 | Aflofarm Fabryka Leków Spółka Z Ograniczoną Odpowiedzialnością | Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania |
CN103284319A (zh) * | 2013-06-20 | 2013-09-11 | 昌宁德康生物科技有限公司 | 一种金雀花碱替代尼古丁口腔雾化液及其制备方法 |
PL408608A1 (pl) | 2014-06-18 | 2015-12-21 | Pharmacia Polonica Spółka Z Ograniczoną Odpowiedzialnością | Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania |
GB201602145D0 (en) * | 2016-02-05 | 2016-03-23 | Achieve Pharma Uk Ltd | Salt |
HUE061016T2 (hu) | 2016-08-19 | 2023-05-28 | Univ Bristol | Citizin-származékok a szenvedélybetegségek kezelésére |
CA3070055A1 (en) * | 2017-07-24 | 2019-01-31 | Achieve Pharma Uk Limited | Cytisine salts |
EP3598968A1 (de) | 2018-07-23 | 2020-01-29 | Adamed Pharma S.A. | Feste pharmazeutische cytisin-zusammensetzung |
BG67408B1 (bg) | 2019-04-12 | 2022-01-17 | Софарма Ад | Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5977131A (en) * | 1997-04-09 | 1999-11-02 | Pfizer Inc. | Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents |
DK1178045T3 (da) * | 1997-04-09 | 2003-06-23 | Pfizer | Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler |
-
2004
- 2004-04-16 BG BG108686A patent/BG65536B1/bg unknown
-
2005
- 2005-02-02 AT AT05472001T patent/ATE401075T1/de not_active IP Right Cessation
- 2005-02-02 DE DE602005008128T patent/DE602005008128D1/de active Active
- 2005-02-02 EP EP05472001A patent/EP1586320B1/de active Active
- 2005-02-02 PL PL05472001T patent/PL1586320T3/pl unknown
- 2005-02-02 SI SI200530386T patent/SI1586320T1/sl unknown
Also Published As
Publication number | Publication date |
---|---|
PL1586320T3 (pl) | 2008-12-31 |
SI1586320T1 (sl) | 2009-02-28 |
BG108686A (en) | 2005-12-30 |
BG65536B1 (bg) | 2008-11-28 |
EP1586320A1 (de) | 2005-10-19 |
DE602005008128D1 (de) | 2008-08-28 |
EP1586320B1 (de) | 2008-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE401075T1 (de) | Cytisinehaltiges arzneimittel | |
TW200505498A (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
UA108594C2 (uk) | Одинична дозована фармацевтична форма | |
MX2007015480A (es) | Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada. | |
HK1096034A1 (en) | A solid dosage form comprising a fibrate | |
EA200801926A1 (ru) | Таблетки парацетамола с быстрым высвобождением | |
NO20043723L (no) | Farmasoytisk doseringform for avgivese gjennom slimhinner | |
WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
ATE488225T1 (de) | Kaubare, lutschbare und verschluckbare tablette mit einer calciumhaltigen verbindung als wirkstoff | |
NO20060445L (no) | Fast farmasoytisk preparat omfattende amisulprid | |
MXPA06010146A (es) | Formas de dosificacion solidas biodisponibles de metaxalona. | |
WO2002024203A3 (en) | Controlled release formulations for oral administration | |
MY127350A (en) | Flash-melt oral dose formulations | |
EA200401097A1 (ru) | Лекарственная форма с регулируемым высвобождением активного ингредиента | |
HUP0402178A2 (hu) | 5 HT1 antagonista hatóanyagot tartalmazó gyógyszerkészítmény | |
ZA200506992B (en) | Fibrate tablet and method for the production thereof | |
WO2008079343A3 (en) | Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients | |
HUP0203148A2 (hu) | Mirtazapint tartalmazó orálisan dezintegrálódó készítmény | |
WO2003061557A3 (en) | Levothyroxine pharmaceutical compositions, methods of making and methods of administration | |
MY141008A (en) | Oral formulations of deoxypeganine and their uses | |
WO2004014318A3 (en) | Levothyroxine compositions and methods | |
WO2003013441A3 (en) | Levothyroxine compositions and methods | |
WO2008147245A3 (fr) | Composition pharmaceutique de proxodolol à libération contrôlée | |
ATE311183T1 (de) | Enalaprilmaleat enthaltende, stabile, feste arzneimittel | |
MY145885A (en) | Controlled release formulations for oral administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |